SGR Repeal: The Initial Impact

It has been a historic week with the bi-partisan passage of H.R. 2 – the Medicare Access and CHIP Reauthorization Act (also referred to as the SGR repeal bill). In the video below, Dennis Olmstead, PAMED’s chief strategy officer and medical economist, discusses its initial impacts for Pennsylvania physicians.